Performance of three clinical scores for steatosis and steatohepatitis and their interaction with metabolic syndrome in obese individuals

Table 4 Odds ratios and interaction effects between clinical scores and metabolic syndrome for predicting steatosis and metabolic dysfunction-associated liver disease

Score	Variable	OR	95%CI	P value
Any steatosis
NLFS	Score	1.15	0.93-1.70	0.353
	MetS	0.88	0.31-2.41	0.809
	Score-MetS interaction	1.24	0.78-1.85	0.295
HSI	Score	0.99	0.09-1.20	0.896
	MetS	< 0.01	< 0.01- > 100	0.904
	Score-MetS interaction	1.00	0.80-1.24	0.966
FLI	Score	0.75	0.42	0.239
	MetS	< 0.01	< 0.01- > 100	0.462
	Score-MetS interaction	1.29	0.67-2.66	0.452
Moderate-to-severe steatosis
NLFS	Score	0.93	0.40-1.22	0.780
	MetS	1.85	0.38-13.63	0.479
	Score-MetS interaction	1.35	0.95-3.25	0.266
HSI	Score	0.87	0.54-1.28	0.518
	MetS	< 0.01	< 0.01- > 100	0.400
	Score-MetS interaction	1.22	0.82-2.00	0.354
FLI	Score	1.63	0.66-10.99	0.471
	MetS	< 0.01	< 0.01- > 100	0.718
	Score-MetS interaction	1.34	0.18-4.84	0.710
MASH
NLFS	Score	1.06	0.87-1.22	0.478
	MetS	0.77	0.20-3.25	0.715
	Score-MetS interaction	1.14	0.90-1.48	0.279
HSI	Score	0.93	0.069-1.20	0.584
	MetS	< 0.01	< 0.01- > 100	0.329
	Score-MetS interaction	0.15	0.87-1.56	0.325
FLI	Score	1.17	0.71-2.93	0.589
	MetS	< 0.01	< 0.01- > 100	0.462
	Score-MetS interaction	1.45	0.48-3.84	0.463

CI: Confidence interval; FLI: Fatty liver index; HSI: Hepatic steatosis index; MASH: Metabolic dysfunction-associated liver disease; MetS: Metabolic syndrome; NLFS: Non-alcoholic fatty liver disease liver fat score; OR: Odds ratio.